These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30825702)

  • 1. Repetitive intrathecal injection of human NMO-IgG with complement exacerbates disease severity with NMO pathology in experimental allergic encephalomyelitis mice.
    Lee CL; Wang KC; Chen SJ; Chen CM; Tsai CP; Chen SY
    Mult Scler Relat Disord; 2019 May; 30():225-230. PubMed ID: 30825702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passively transferred human NMO-IgG exacerbates demyelination in mouse experimental autoimmune encephalomyelitis.
    Saini H; Rifkin R; Gorelik M; Huang H; Ferguson Z; Jones MV; Levy M
    BMC Neurol; 2013 Aug; 13():104. PubMed ID: 23927715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
    Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
    J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin oligodendrocyte glycoprotein induces aquaporin-4 autoantibodies in mouse experimental autoimmune encephalomyelitis.
    Wu X; Zhou M; Ding H; Xu S; Wang C; Chan P
    J Neuroimmunol; 2013 Aug; 261(1-2):1-6. PubMed ID: 23707078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Frequency Ultrasound With Injection of NMO-IgG and Complement Produces Lesions Different From Experimental Autoimmune Encephalomyelitis Mice.
    Xiang W; Xie C; Luo J; Zhang W; Zhao X; Yang H; Cai Y; Ding J; Wang Y; Hao Y; Zhang Y; Guan Y
    Front Immunol; 2021; 12():727750. PubMed ID: 34721390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody.
    Kurosawa K; Misu T; Takai Y; Sato DK; Takahashi T; Abe Y; Iwanari H; Ogawa R; Nakashima I; Fujihara K; Hamakubo T; Yasui M; Aoki M
    Acta Neuropathol Commun; 2015 Dec; 3():82. PubMed ID: 26637322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Brown Norway opticospinal model of demyelination: does it mimic multiple sclerosis or neuromyelitis optica?
    Collongues N; Chanson JB; Blanc F; Steibel J; Lam CD; Shabbir A; Trifilieff E; Honnorat J; Pham-Dinh D; Ghandour MS; de Seze J
    Int J Dev Neurosci; 2012 Oct; 30(6):487-97. PubMed ID: 22634288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms.
    Zhang H; Bennett JL; Verkman AS
    Ann Neurol; 2011 Dec; 70(6):943-54. PubMed ID: 22069219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaporin-4 autoantibodies cause asymptomatic aquaporin-4 loss and activate astrocytes in mouse.
    Chan KH; Zhang R; Kwan JS; Guo VY; Ho PW; Ho JW; Chu AC
    J Neuroimmunol; 2012 Apr; 245(1-2):32-8. PubMed ID: 22394609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
    Yao X; Verkman AS
    Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of iron homeostasis proteins in the spinal cord in experimental autoimmune encephalomyelitis and their implications for iron accumulation.
    Zarruk JG; Berard JL; Passos dos Santos R; Kroner A; Lee J; Arosio P; David S
    Neurobiol Dis; 2015 Sep; 81():93-107. PubMed ID: 25724358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59.
    Zhang H; Verkman AS
    J Autoimmun; 2014 Sep; 53():67-77. PubMed ID: 24698947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
    Asavapanumas N; Verkman AS
    Acta Neuropathol Commun; 2014 Apr; 2():48. PubMed ID: 24758159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
    Abad C; Jayaram B; Becquet L; Wang Y; O'Dorisio MS; Waschek JA; Tan YV
    J Neuroinflammation; 2016 Jun; 13(1):169. PubMed ID: 27357191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
    Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
    Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG.
    Asavapanumas N; Ratelade J; Verkman AS
    Acta Neuropathol; 2014 Apr; 127(4):539-51. PubMed ID: 24190619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].
    Misu T; Fujihara K; Itoyama Y
    Brain Nerve; 2008 May; 60(5):527-37. PubMed ID: 18516975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model.
    Geis C; Ritter C; Ruschil C; Weishaupt A; Grünewald B; Stoll G; Holmoy T; Misu T; Fujihara K; Hemmer B; Stadelmann C; Bennett JL; Sommer C; Toyka KV
    Exp Neurol; 2015 Mar; 265():8-21. PubMed ID: 25542977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.